CN101035891A - 卵磷脂化超氧化物歧化酶组合物及其制备方法 - Google Patents
卵磷脂化超氧化物歧化酶组合物及其制备方法 Download PDFInfo
- Publication number
- CN101035891A CN101035891A CNA2005800343890A CN200580034389A CN101035891A CN 101035891 A CN101035891 A CN 101035891A CN A2005800343890 A CNA2005800343890 A CN A2005800343890A CN 200580034389 A CN200580034389 A CN 200580034389A CN 101035891 A CN101035891 A CN 101035891A
- Authority
- CN
- China
- Prior art keywords
- sod
- superoxide dismutase
- lecithinized superoxide
- lecithinized
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP297519/2004 | 2004-10-12 | ||
JP2004297519 | 2004-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101035891A true CN101035891A (zh) | 2007-09-12 |
CN100516208C CN100516208C (zh) | 2009-07-22 |
Family
ID=36148275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005800343890A Active CN100516208C (zh) | 2004-10-12 | 2005-10-05 | 卵磷脂化超氧化物歧化酶组合物及其制备方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7700336B2 (zh) |
EP (1) | EP1803808B1 (zh) |
JP (1) | JP4958556B2 (zh) |
KR (1) | KR101183856B1 (zh) |
CN (1) | CN100516208C (zh) |
CA (1) | CA2584406C (zh) |
ES (1) | ES2402774T3 (zh) |
WO (1) | WO2006040980A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966334A (zh) * | 2010-09-29 | 2011-02-09 | 北京泰德制药股份有限公司 | 卵磷脂化超氧化物歧化酶组合物在制备治疗和/或预防心脏缺血损伤的药物中的应用 |
CN102238958A (zh) * | 2008-12-03 | 2011-11-09 | 日本株式会社Ltt生物医药 | 含有修饰型超氧化物歧化酶的吸入剂 |
CN109422796A (zh) * | 2017-09-04 | 2019-03-05 | 北京泰德制药股份有限公司 | 一种蛋白卵磷脂化修饰的方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2440568B1 (en) * | 2009-06-02 | 2015-02-25 | Brandeis University | Cross-linking of superoxide dismutase monomers |
CN106754770A (zh) * | 2016-12-05 | 2017-05-31 | 璧典匠 | 一种超氧化物歧化酶的层析纯化制备方法 |
KR102157645B1 (ko) * | 2018-09-12 | 2020-09-18 | 정철민 | 캡슐화된 수퍼옥사이드 디스뮤타아제를 함유하는 화장료 조성물의 제조방법. |
AU2022278242A1 (en) | 2021-05-18 | 2023-11-30 | Ltt Bio-Pharma Co., Ltd. | Pharmaceutical composition for treating or preventing disorder associated with administration of anticancer agent |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0262829A (ja) * | 1988-05-18 | 1990-03-02 | Nippon Kayaku Co Ltd | 虚血に基づく傷害の予防及び治療剤 |
US5109118A (en) | 1989-07-06 | 1992-04-28 | Yutaka Mizushima | Modified biologically active proteins |
JP3070980B2 (ja) | 1991-06-07 | 2000-07-31 | 株式会社エルティーティー研究所 | レシチン化スーパーオキシドディスムターゼ及びそれを有効成分とする医薬 |
JPH08208511A (ja) * | 1995-01-31 | 1996-08-13 | Samu Kenkyusho:Kk | 抗運動ニューロン疾患剤 |
JPH09110717A (ja) * | 1995-10-21 | 1997-04-28 | Samu Kenkyusho:Kk | ループス腎炎治療剤 |
JP3857338B2 (ja) * | 1995-10-25 | 2006-12-13 | 株式会社Lttバイオファーマ | レシチン化スーパーオキシドディスムターゼおよびそれを有効成分とする医薬 |
DE60037190T2 (de) * | 1999-06-24 | 2008-03-20 | Ltt Bio-Pharma Co., Ltd. | Medikamentzusammensetzung die lecithin-modifizierte superoxiddismutase enthält |
-
2005
- 2005-10-05 EP EP05790438A patent/EP1803808B1/en active Active
- 2005-10-05 JP JP2006540893A patent/JP4958556B2/ja active Active
- 2005-10-05 WO PCT/JP2005/018454 patent/WO2006040980A1/ja active Application Filing
- 2005-10-05 CA CA2584406A patent/CA2584406C/en active Active
- 2005-10-05 KR KR1020077006634A patent/KR101183856B1/ko active IP Right Grant
- 2005-10-05 ES ES05790438T patent/ES2402774T3/es active Active
- 2005-10-05 CN CNB2005800343890A patent/CN100516208C/zh active Active
-
2007
- 2007-04-11 US US11/733,989 patent/US7700336B2/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102238958A (zh) * | 2008-12-03 | 2011-11-09 | 日本株式会社Ltt生物医药 | 含有修饰型超氧化物歧化酶的吸入剂 |
CN101966334A (zh) * | 2010-09-29 | 2011-02-09 | 北京泰德制药股份有限公司 | 卵磷脂化超氧化物歧化酶组合物在制备治疗和/或预防心脏缺血损伤的药物中的应用 |
CN109422796A (zh) * | 2017-09-04 | 2019-03-05 | 北京泰德制药股份有限公司 | 一种蛋白卵磷脂化修饰的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100516208C (zh) | 2009-07-22 |
CA2584406A1 (en) | 2006-04-20 |
WO2006040980A1 (ja) | 2006-04-20 |
ES2402774T3 (es) | 2013-05-08 |
EP1803808B1 (en) | 2013-03-27 |
KR20070085234A (ko) | 2007-08-27 |
JP4958556B2 (ja) | 2012-06-20 |
US7700336B2 (en) | 2010-04-20 |
EP1803808A4 (en) | 2008-12-31 |
EP1803808A1 (en) | 2007-07-04 |
JPWO2006040980A1 (ja) | 2008-05-15 |
KR101183856B1 (ko) | 2012-09-19 |
US20070178080A1 (en) | 2007-08-02 |
CA2584406C (en) | 2012-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101035891A (zh) | 卵磷脂化超氧化物歧化酶组合物及其制备方法 | |
CN1045162C (zh) | 治疗肿瘤病药品的制备方法 | |
CN1310885C (zh) | 4-氟-2-氰基吡咯烷衍生物苯磺酸盐 | |
CN1914228A (zh) | 透明质酸与大黄酸的酯,它们的制备方法及含有它们的组合物 | |
CN1449412A (zh) | Dds化合物及其制备方法 | |
CN1378447A (zh) | 穿透细胞膜的靛类双吲哚衍生物的用途 | |
CN1775215A (zh) | 盐酸阿扎司琼葡萄糖注射液制剂、制备方法及其质量控制技术 | |
CN101068769A (zh) | 治疗和/或预防糖尿病的芳烷基胺钒(v)盐 | |
CN1037266C (zh) | 喹啉衍生物的富马酸盐及其制法和其药物组合物 | |
CN1263736C (zh) | 四水合n-[邻-(对-三甲基乙酰氧基苯磺酰胺基)苯甲酰基]甘氨酸单钠盐的溶液及其药品 | |
CN1649873A (zh) | 喜树碱-紫杉烷类共轭物作为抗有丝分裂和抗肿瘤剂 | |
CN1871253A (zh) | 糖肽膦酸酯衍生物的盐酸盐 | |
CN1040328C (zh) | 血卟啉和其衍生物的复合盐的制备方法 | |
CN1272069C (zh) | 含有睫状神经营养因子类似物的稳定药剂 | |
CN85107053A (zh) | 制备双吲哚金属络合物及含这种金属络合物组分的药用水溶液的方法 | |
CN1503782A (zh) | 海绵内酯酸的某些盐、含有它们的药物组合物及其在治疗肿瘤中的用途 | |
CN1903180A (zh) | 注射用呋塞米冻干制剂及制备方法 | |
CN1099753A (zh) | 氨基-抗坏血酸衍生物,它们的制备方法及应用 | |
CN114177302B (zh) | 一种用于抗肿瘤药物递送的糖胺聚糖改性物及其制备方法与应用 | |
CN1668643A (zh) | 葡聚糖-血红蛋白共轭物作为血液代用品 | |
CN1850797A (zh) | 硫普罗宁氨基酸盐及其制备方法 | |
CN1451369A (zh) | 环糊精衍生物在化妆品中的应用 | |
CN100344324C (zh) | 干扰素脂质体乳膏 | |
BE1028852A1 (fr) | PRODROGUE DU 5α-hydroxy-6β-[2-(1H-imidazol-4-yl) éthylamino]cholestan-3β-ol ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER | |
CN117561266A (zh) | 噻唑并内酰胺并螺杂环类化合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LTT BIO PHARMA CO., LTD.; APPLICANT Free format text: FORMER OWNER: LTT BIO PHARMA CO., LTD. Effective date: 20071026 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20071026 Address after: Tokyo, Japan Applicant after: LTT Bio Pharma Co., Ltd. Co-applicant after: Taide Pharma Co., Ltd., Beijing Address before: Tokyo, Japan Applicant before: LTT Bio Pharma Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Tokyo, Japan Co-patentee after: Beijing Tide Pharmaceutical Co., Ltd. Patentee after: LTT Bio Pharma Co., Ltd. Address before: Tokyo, Japan Co-patentee before: Taide Pharma Co., Ltd., Beijing Patentee before: LTT Bio Pharma Co., Ltd. |